Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients

Clinical Nephrology

Volumn 57, Issue 6, 2002, Pages 457-461

  Hoen, B ^a   Paul Dauphin, A ^a   Kessler, M ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Bacteremia; Hemodialysis; Intravenous iron administration; Iron therapy

Indexed keywords

ERYTHROPOIETIN; IRON;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ADMINISTRATION ROUTE; DRUG MEGADOSE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; IRON DEFICIENCY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT;

EID: 0035985424     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP57457     Document Type: Article

References (13)

1. European best practice guidelines for the management of anaemia in patients with chronic renal failure - Target guideline 6: Assessing and optimizing iron stores
2. European best practice guidelines for the management of anaemia in patients with chronic renal failure - Guideline 8: Administration of supplemental iron
3. Frequent IV dosing is associated with higher infectious deaths
4. IV iron dosing patterns and mortality
5. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
6. Iron administration and clinical outcomes in hemodialysis patients
7. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
8. Risk factors for bacterial infections in chronic haemodialysis adult patients: A multicentre prospective survey
9. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients
10. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey
11. Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit
12. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency
13. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine